We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$6.26B
AUM Growth
+$473M
Cap. Flow
+$398M
Cap. Flow %
6.35%
Top 10 Hldgs %
23.68%
Holding
293
New
38
Increased
125
Reduced
71
Closed
38

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$53.8M
2
ELV icon
Elevance Health
ELV
+$34.6M
3
AET
Aetna Inc
AET
+$33.5M
4
WBA
Walgreens Boots Alliance
WBA
+$32.4M
5
AME icon
Ametek
AME
+$29.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$48.5M
2
MRK icon
Merck
MRK
+$37.3M
3
AMGN icon
Amgen
AMGN
+$35M
4
EW icon
Edwards Lifesciences
EW
+$29.3M
5
BAH icon
Booz Allen Hamilton
BAH
+$26.3M

Sector Composition

Rank Sector Weight
1 Financials 23.24%
2 Technology 21.39%
3 Healthcare 21.13%
4 Communication Services 9.82%
5 Industrials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HR
226
DELISTED
Healthcare Realty Trust Incorporated
HR
$1.82M 0.03%
60,000
– –
HDB icon
227
HDFC Bank
HDB
$119B
$1.8M 0.03%
118,732
+55,664
+88% +$931K
SGEN
228
DELISTED
Seagen Inc. Common Stock
SGEN
$1.58M 0.03%
+30,000
New +$1.8M
CSLT
229
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.57M 0.03%
317,260
-202,444
-39% -$917K
OHI icon
230
Omega Healthcare
OHI
$15.3B
$1.56M 0.02%
50,000
– –
PRLB icon
231
Protolabs
PRLB
$1.85B
$1.53M 0.02%
29,823
-7,951
-21% -$417K
HCSG icon
232
Healthcare Services Group
HCSG
$1.58B
$1.5M 0.02%
38,372
– –
MTLS
233
Materialise
MTLS
$373M
$1.28M 0.02%
167,742
-79,048
-32% -$607K
TSLA icon
234
Tesla
TSLA
$1.22T
$1.21M 0.02%
85,200
– –
VRTX icon
235
Vertex Pharmaceuticals
VRTX
$122B
$1.1M 0.02%
15,000
-3,500
-19% -$285K
PCRX icon
236
Pacira BioSciences
PCRX
$1.04B
$808K 0.01%
25,000
-9,100
-27% -$304K
VIVO
237
DELISTED
Meridian Bioscience Inc
VIVO
$789K 0.01%
44,600
– –
BKD icon
238
Brookdale Senior Living
BKD
$3.69B
$745K 0.01%
60,000
– –
ARDX icon
239
Ardelyx
ARDX
$1.25B
$710K 0.01%
+50,000
New +$710K
NGNE icon
240
Neurogene
NGNE
$691M
$578K 0.01%
+1,750
New +$471K
ACAD icon
241
Acadia Pharmaceuticals
ACAD
$4.35B
$577K 0.01%
20,000
+8,750
+78% +$231K
CFG icon
242
Citizens Financial Group
CFG
$30.1B
$446K 0.01%
12,517
-5,190
-29% -$157K
OPB
243
DELISTED
Opus Bank Common Stock
OPB
$399K 0.01%
13,291
+1,232
+10% +$32.9K
AMGN icon
244
Amgen
AMGN
$203B
$256K ﹤0.01%
1,750
-232,263
-99% -$35M
EEM icon
245
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$255K ﹤0.01%
7,293
+531
+8% +$19.2K
ADAP
246
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-60,000
Closed -$423K
BLUE
247
DELISTED
bluebird bio
BLUE
– –
-11,787
Closed -$10.3M
CHRS icon
248
Coherus Oncology
CHRS
$225M
– –
-15,000
Closed -$402K
COO icon
249
Cooper Companies
COO
$13.7B
– –
-472,000
Closed -$21.2M
EW icon
250
Edwards Lifesciences
EW
$47.8B
– –
-728,790
Closed -$29.3M
7 8 9
10
11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Polar Capital held 293 positions worth $6.26B, up 8.2% from $5.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $398M of net new capital in Q4 2016, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Aetna Inc: 279,500 shares worth $34.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $48.5M trimmed.

  • Polar Capital's largest Q4 2016 buy was Aetna Inc: 279,500 shares worth $34.7M.
  • Polar Capital added most to Alexion Pharmaceuticals in Q4 2016, an estimated $53.8M increase.
  • Polar Capital's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $48.5M.
  • Polar Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $29.3M.
  • Polar Capital's ten largest holdings make up 24% of its $6.26B portfolio in Q4 2016.
  • Polar Capital opened 38 new positions and closed 38 in Q4 2016.
  • Polar Capital's portfolio value rose 8.2% quarter-over-quarter to $6.26B.

Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.